Ganoderma lucidum polysaccharides improve lipid metabolism against high-fat diet-induced dyslipidemia

J Ethnopharmacol. 2023 Jun 12:309:116321. doi: 10.1016/j.jep.2023.116321. Epub 2023 Mar 1.

Abstract

Ethnopharmacological relevance: As a kind of traditional medicinal fungi, Ganoderma lucidum has been employed as folk medicine in China against multiple metabolic diseases on account of its superior bioactivities. Recently, accumulated reports have investigated the protective effects of G. lucidum polysaccharides (GLP) on ameliorating dyslipidemia. However, the specific mechanism by which GLP improves dyslipidemia is not completely clear.

Aims of the study: This study aimed to investigate the protective effects of GLP on high-fatdiet-induced hyperlipidemia and exploring its underlying mechanism.

Materials and methods: The GLP was successfully obtained from G. lucidum mycelium. The mice were conducted with high-fatdiet to establish the hyperlipidemia model. Biochemical determination, histological analysis, immunofluorescence, western blot and real-time qPCR were used to assess the alterations in high-fatdiet-treated mice after the GLP intervention.

Results: It was found that GLP administration significantly decreased body weight gain and the excessive lipid levels, and partly alleviated tissue injury. Oxidative stress and inflammations were efficiently ameliorated after the treatment of GLP by activing Nrf2-Keap1 and inhibiting NF-κB signal pathways. GLP promoted cholesterol reverse transport by LXRα-ABCA1/ABCG1 signaling, increased the expressions of CYP7A1 and CYP27A1 responsible for bile acids production, accompanied by inhibition of intestinal FXR-FGF15 levels. Besides, multiple target proteins involved in lipid metabolism were also significantly modulated under the intervention of GLP.

Conclusion: Taken together, our results suggested that GLP showed potential lipid-lowering effects and its possible mechanism was involved in improving oxidative stress and inflammation response, modulating bile acids synthesis and lipid regulatory factors, and promoting reverse cholesterol transport, thereby suggesting that GLP may possibly used as a dietary supplement or medication for the adjuvant therapy for hyperlipidemia.

Keywords: Antioxidation; Ganoderma lucidum polysaccharides; Hyperlipidemia; Inflammation; Lipid metabolism.

MeSH terms

  • Animals
  • Bile Acids and Salts
  • Cholesterol
  • Diet, High-Fat / adverse effects
  • Dyslipidemias* / drug therapy
  • Kelch-Like ECH-Associated Protein 1
  • Lipid Metabolism
  • Lipids
  • Mice
  • NF-E2-Related Factor 2
  • Polysaccharides / pharmacology
  • Polysaccharides / therapeutic use
  • Reishi*

Substances

  • Kelch-Like ECH-Associated Protein 1
  • NF-E2-Related Factor 2
  • Polysaccharides
  • Cholesterol
  • Bile Acids and Salts
  • Lipids